MEDFORMIN 1000 metformin hydrochloride 1000mg tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

metformin hydrochloride, Quantity: 1000 mg

Disponível em:

Arrotex Pharmaceuticals Pty Ltd

DCI (Denominação Comum Internacional):

Metformin hydrochloride

Forma farmacêutica:

Tablet, film coated

Composição:

Excipient Ingredients: povidone; magnesium stearate; hypromellose; macrogol 400

Via de administração:

Oral

Unidades em pacote:

10 tablets, 60 tablets, 100 tablets, 90 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Metformin is indicated in the treatment of type 2 diabetes mellitus not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. Metformin may be used as initial therapy or in sulfonylurea failure, either alone or in combination with a sulfonylurea or as adjuvant therapy in insulin-dependent diabetes.

Resumo do produto:

Visual Identification: OVAL, WHITE TABLET, EMBOSSED WITH "MO" ON ONE SIDE AND TWO ARROW SYMBOLS ON EITHER SIDE OF A SCORELINE ON THE OTHER.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2004-11-15